Patient‐Reported Outcomes in the Phase III OASIS‐HAE Study of Donidalorsen for Hereditary Angioedema

Authors

Institutions

Publication Details

Journal
Allergy
Published
2025-04-19
DOI
https://doi.org/10.1111/all.16563
Citations
4
Primary Topic
Coagulation, Bradykinin, Polyphosphates, and Angioedema
Type
article
Field-Weighted Citation Impact
6.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient‐Reported Outcomes in the Phase III OASIS‐HAE Study of Donidalorsen for Hereditary Angioedema

Danny M. Cohn, Sabrina Treadwell, Marc A. Riedl, Aaron Yarlas et al.
4 citations
Allergy
Coagulation, Bradykinin, Polyphosphates, and Angioedema
6.50
article

Patient‐Reported Outcomes in the Phase III OASIS‐HAE Study of Donidalorsen for Hereditary Angioedema

Danny M. Cohn, Sabrina Treadwell, Marc A. Riedl, Aaron Yarlas, Ken B. Newman, Sophie X. Wang, Laura Bordone
article en
4 citations

Abstract

No abstract available for this paper.
AllergyVol. 80(8)
Ionis Pharmaceuticals (United States) (US), University of California San Diego (US), Amsterdam University Medical Centers (NL), University of Amsterdam (NL)
Ionis Pharmaceuticals
Decent work and economic growth
Openalex Percentile: Top 4%
Coagulation, Bradykinin, Polyphosphates, and Angioedema
6.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.